We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

39 hedge funds and large institutions have $7.14M invested in vTv Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

0.01% more ownership

Funds ownership: 0.2% → 0.21% (+0.01%)

0% more funds holding

Funds holding: 39 → 39 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

12% less capital invested

Capital invested by funds: $8.1M → $7.14M (-$965K)

Holders
39
Holders Change
–
Holders Change %
0%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
15
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$693K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$525K
3
Wells Fargo
Wells Fargo
California
+$187K
4
BlackRock
BlackRock
New York
+$97.1K
5
Two Sigma Investments
Two Sigma Investments
New York
+$87K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$347K
2
Renaissance Technologies
Renaissance Technologies
New York
-$299K
3
Squarepoint
Squarepoint
New York
-$58.7K
4
Goldman Sachs
Goldman Sachs
New York
-$43K
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
1
Frazier Management
Washington
$1.88M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.25M +$525K +5,971 +51%
Two Sigma Investments
3
Two Sigma Investments
New York
$889K +$87K +990 +9%
Two Sigma Advisers
4
Two Sigma Advisers
New York
$849K +$693K +7,887 +192%
BlackRock
5
BlackRock
New York
$660K +$97.1K +1,105 +13%
State Street
6
State Street
Massachusetts
$311K -$1.41K -16 -0.4%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$299K +$1.14K +13 +0.3%
Northern Trust
8
Northern Trust
Illinois
$243K -$5.18K -59 -2%
Wells Fargo
9
Wells Fargo
California
$159K +$187K +2,123 +1,561%
N
10
Nuveen
North Carolina
$74K +$23.1K +263 +34%
New York State Common Retirement Fund
11
New York State Common Retirement Fund
New York
$73K – – –
GCP
12
GSA Capital Partners
United Kingdom
$68K +$84.2K +958 New
Squarepoint
13
Squarepoint
New York
$58K -$58.7K -668 -45%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$44K +$1.32K +15 +2%
WS
15
Wedbush Securities
California
$39K +$3.08K +35 +7%
Charles Schwab
16
Charles Schwab
California
$38K – – –
Jane Street
17
Jane Street
New York
$28K -$14.3K -163 -29%
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$26K – – –
Citadel Advisors
19
Citadel Advisors
Florida
$26K +$31.9K +363 New
AllianceBernstein
20
AllianceBernstein
Tennessee
$19K -$4.39K -50 -16%
TRCT
21
Tower Research Capital (TRC)
New York
$17K -$2.11K -24 -9%
JP Morgan Chase
22
JP Morgan Chase
New York
$15K +$264 +3 +2%
UBS Group
23
UBS Group
Switzerland
$15K +$9.32K +106 +98%
AIG
24
American International Group
New York
$11K +$703 +8 +5%
Barclays
25
Barclays
United Kingdom
$9K -$1.32K -15 -11%
1
2

VTVT Hedge Fund Activity: Q3 2020 in Review

39 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2020, worth a combined $7.14M — down 12% from $8.1M a quarter earlier.

Fund positioning in VTVT was balanced in Q3 2020: 5 funds opened new positions, 5 closed out, 15 added to existing stakes and 11 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $693K. The largest seller was Virtu Financial, exiting entirely with an estimated $347K sold.

  • 39 institutional investors held vTv Therapeutics (VTVT) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $7.14M of vTv Therapeutics stock for Q3 2020, down 12% quarter-over-quarter.
  • 5 funds opened new vTv Therapeutics positions in Q3 2020 and 5 closed out, a net change of 0 holders.
  • The largest vTv Therapeutics buyer in Q3 2020 was Two Sigma Advisers, an estimated $693K added.
  • The largest vTv Therapeutics seller in Q3 2020 was Virtu Financial, an estimated $347K sold.

Based on aggregated 13F filings for Q3 2020.